Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
allogeneic hematopoietic cell transplantation
immunosuppression
medication adherence
Journal
Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
09
06
2020
received:
10
10
2019
accepted:
27
07
2020
pubmed:
3
8
2020
medline:
9
10
2021
entrez:
3
8
2020
Statut:
ppublish
Résumé
Medication non-adherence (NA) after allogeneic hematopoietic cell transplantation (allo-HCT) can lead to serious complications. This study assesses NA in French adult and pediatric recipients and identifies factors associated with NA. In accordance with the EMERGE and STROBE guidelines, a cross sectional multicentric survey was conducted. We used a self-reported questionnaire that was adapted to adults and pediatrics and that could provide a picture of all three phases of medication adherence: initiation, implementation, persistence. We enrolled 242 patients, 203 adults (mean age: 51 years old, 50.7% male) and 39 children (mean age: 9 years old, 56.4% female). Reported NA was estimated at about 75% in both populations, adults and pediatrics. In adults, the univariate analysis showed that patients less than 50 years old (P = 0.041), (i) treated with cyclosporine (P = 0.02), (ii) treated with valacyclovir/acyclovir (P = 0.016), and (iii) experiencing side effects (P = 0.009), were significantly more non-adherent. In multivariate analysis, only recipient age was significantly associated to NA (P = 0.05). The limited size of the pediatric population did not allow us to draw any statistical conclusion about this population. To the best of our knowledge, this is the first study in France on NA in allo-HCT recipients. Our results highlight the age factor as the only factor related to NA. Further studies are needed to confirm our observations and refine results in pediatric populations, currently most at risk of medication NA.
Substances chimiques
Cyclosporine
83HN0GTJ6D
Acyclovir
X4HES1O11F
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
435-445Informations de copyright
© 2020 Société Française de Pharmacologie et de Thérapeutique.
Références
Morrison C.F., Martsolf D.M., Wehrkamp N., Tehan R., Pai A.L.H. Medication adherence in hematopoietic stem cell transplantation: a review of the literature. Biol. Blood Marrow Transplant. (2017) 23 562-568.
World Health Oganiation. Adherence to long-term therapies [Internet]. 2003. Disponible sur: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1.
De-Geest S., Zullig L.L., Dunbar-Jacob J., et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann. Intern. Med. (2018) 169 30-35.
Russell C.L., Cetingok M., Hamburger K.Q., et al. Medication adherence in older renal transplant recipients. Clin. Nurs. Res. (2010) 19 95-112.
Brahm M.M.T., Manfro R.C., Mello D., Cioato S., Gonçalves L.F.S. Evaluation of adherence to immunosuppressive drugs in kidney transplantation by control of medication dispensing. Transpl. Proc. (2012) 44 2391-2393.
Denhaerynck K., Dobbels F., Cleemput I., et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl. Int. (2005) 18 1121-1133.
Belaiche S., Décaudin B., Dharancy S., Noel C., Odou P., Hazzan M. Factors relevant to medication non-adherence in kidney transplant: a systematic review. Int. J. Clin Pharm. (2017) 39 582-593.
Michelon T., Dominguez V., Losekan A., et al. Kidney graft failure due to noncompliance. Transplant. Proc. (1999) 31 3031-3032.
Hansen R., Seifeldin R., Noe L. Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant. Proc. (2007) 39 1287-1300.
Rianthavorn P., Ettenger R.B., Malekzadeh M., Marik J.L., Struber M. Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. Transplantation. (2004) 77 778-782.
Dharancy S., Giral M., Tetaz R., Fatras M., Dubel L., Pageaux G.-P. Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin. Transplant. (2012) 26 E293-E299.
Dobbels F., Ruppar T., De Geest S., Decorte A., Van Damme-Lombaerts R., Fine R.N. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr. Transplant. (2010) 14 603-613.
Chisholm M.A., Vollenweider L.J., Mulloy L.L., et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. (2000) 70 1240-1244.
Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. (2001) 23 1296-310.
Couzi L., Moulin B., Morin M.-P., et al. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation. (2013) 95 326-332.
Hugon A., Roustit M., Lehmann A., et al. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Transplantation. (2014) 98 222-228.
Belaiche S., Décaudin B., Dharancy S., et al. Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year. Fundam. Clin. Pharmacol. (2017) 25 88-97.
Burra P., Germani G., Gnoato F., et al. Adherence in liver transplant recipients. Liver Transpl.(2011) 17 760-770.
Fredericks E.M. Nonadherence and the transition to adulthood. Liver Transpl. (2009) 15(Suppl. 2) S63-S69.
Farmer S.A., Grady K.L., Wang E., McGee E.C. Jr., Cotts W.G., McCarthy P.M. Demographic, psychosocial, and behavioral factors associated with survival after heart transplantation. Ann. Thorac. Surg. (2013) 95 876-883.
Harden P.N., Walsh G., Bandler N., et al. Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure. BMJ (2012) 344 e3718.
Gilleland J., Amaral S., Mee L., Blount R. Getting ready to leave: transition readiness in adolescent kidney transplant recipients. J. Pediatr. Psychol. (2012) 37 85-96.
Kiberd J.A., Acott P., Kiberd B.A. Kidney transplant survival in pediatric and young adults. BMC Nephrol. (2011) 12 54.
McDonagh J.E., Kelly D.A. The challenges and opportunities for transitional care research. Pediatr. Transplant. (2010) 14 688-700.
Dommergues J.P., Letierce A., Gravereau L., Plainguet F., Bernard O., Debray D. Current lifestyle of young adults after liver transplantation during childhood. Am. J. Transplant. (2010) 10 1634-1642.
Steinberg E.A., Moss M., Buchanan C.L., Goebel J. Adherence in pediatric kidney transplant recipients: solutions for the system. Pediatr. Nephrol. (2018) 33 361-372.
Shemesh E., Annunziato R.A., Arnon R., Miloh T., Kerkar N. Adherence to medical recommendations and transition to adult services in pediatric transplant recipients. Curr. Opin. Organ. Transplant. (2010) 15 288-292.
Zhou J., Han J., Nutescu E.A., Patel P.R., Sweiss K., Calip G.S. Discontinuation and nonadherence to medications for chronic conditions after hematopoietic cell transplantation: a 6-year propensity score-matched cohort study. Pharmacotherapy (2019) 39 55-66.
Lehrer J., Brissot E., Ruggeri A., et al. Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study. Bone Marrow Transplant. (2018) 53 231-233.
Pai A.L.H., Rausch J., Drake S., et al. Poor adherence is associated with more infections after pediatric hematopoietic stem cell transplant. Biol. Blood Marrow Transplant. (2018) 24 381-385.
Gresch B., Kirsch M., Fierz K., et al. Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study. Bone Marrow Transplant. (2017) 52 304-306.
McGrady M.E., Williams S.N., Davies S.M., Pai A.L.H. Adherence to outpatient oral medication regimens in adolescent hematopoietic stem cell transplant recipients. Eur. J. Oncol. Nurs. (2014) 18 140-144.
Fine R.N., Becker Y., De Geest S., et al. Nonadherence consensus conference summary report. Am. J. Transplant. (2009) 9 35-41.
Prendergast M.B., Gaston R.S. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin. J. Am. Soc. Nephrol. (2010) 5 1305-1311.
Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. (2005) 353 487-497.
Editors T.P.M. Observational studies: getting clear about transparency. PLoS Med. (2014) 11 e1001711.
Charan J., Biswas T. How to calculate sample size for different study designs in medical research? Indian J. Psychol. Med. (2013) 35 121-126.
Belaiche S., Yafour N., Balcaen S., et al. Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC. Pathol. Biol. (2014) 62 197-203.
Belaiche S., Balcaen S., Chabanon V., Colledani F., Fournier I., Taque S. L’adhésion thérapeutique : état des lieux en allogreffe de cellules souches hématopoïétiques dans des services de pédiatrie et d’adulte Rapport de la SFGM-TC. Hématologie. (2015) 21 84-91.
Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. (2008) 10 348-354.
Mumby P.B., Hurley C., Samsi M., Thilges S., Parthasarathy M., Stiff P.J. Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplant. (2012) 47 556-561.
Pai A.L.H., Tackett A., Ittenbach R.F., Goebel J. Psychosocial assessment tool 2.0_General: validity of a psychosocial risk screener in a pediatric kidney transplant sample. Pediatr. Transplant. (2012) 16 92-98.
Goldfarb-Rumyantzev A.S., Wright S., Ragasa R., et al. Factors associated with nonadherence to medication in kidney transplant recipients. Nephron Clin. Pract. (2011) 117 c33-c39.
Russell C.L., Owens S., Hamburger K.Q., et al. Medication adherence and older renal transplant patients’ perceptions of electronic medication monitoring. J. Gerontol. Nurs. (2009) 35 17-21.
Pinsky B.W., Takemoto S.K., Lentine K.L., Burroughs T.E., Schnitzler M.A., Salvalaggio P.R. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am. J. Transplant. (2009) 9 2597-606.
Israni A.K., Weng F.L., Cen Y.-Y., Joffe M., Kamoun M., Feldman H.I. Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation. Clin. Transplant. (2011) 25 E124-E131.
Griva K., Davenport A., Harrison M., Newman S.P. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann. Behav. Med. (2012) 44 85-93.
Kirsch M., Berben L., Johansson E., et al. Nurses’ practice patterns in relation to adherence-enhancing interventions in stem cell transplant care: a survey from the Nurses Group of the European Group for Blood and Marrow Transplantation. Eur. J. Cancer Care (2014) 23 607-615.
Garfield S., Clifford S., Eliasson L., Barber N., Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med. Res. Methodol. (2011) 11 149.
Dobbels F., Berben L.,De Geest S., et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplant. J. (2010) 90 205-219.
Chisholm-Burns M., Pinsky B., Parker G., et al. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin. Transplant. (2012) 26 706-713.
Spivey C.A., Chisholm-Burns M.A., Damadzadeh B., Billheimer D. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Clin. Transplant. (2014) 28(1) 96-104.
Cheng C.-Y., Lin B.Y.-J., Chang K.-H., Shu K.-H., Wu M.-J. Awareness of memory impairment increases the adherence to immunosuppressants in kidney transplant recipients. Transplant. Proc. (2012) 44 746-748.
Hardinger K.L., Hutcherson T., Preston D., Murillo D. Influence of pill burden and drug cost on renal function after transplantation. Pharmacotherapy (2012) 32(5) 427-432.
Sabbatini M., Garofalo G., Borrelli S., et al. Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study. Patient Prefer. Adherence. (2014) 8 73-81.
Jindal R.M., Neff R.T., Abbott K.C., et al. Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system. Transplant. Proc. (2009) 41 3662-3666.
Cukor D., Rosenthal D.S., Jindal R.M., Brown C.D., Kimmel P.L. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. (2009) 75 1223-1229.
Pascazio L., Nardone I.B., Clarici A., et al. Anxiety, depression and emotional profile in renal transplant recipients and healthy subjects: a comparative study. Transplant. Proc. (2010) 42 3586-3590.
Kadioglu Z.O., Kacar S., Eroglu A., Guven B., Tilif S. Dyadic adjustment and psychological concordance of kidney transplant recipients and donors after spousal transplantation. Transplant. Proc. (2012) 44 1608-1613.